3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
1
Liver Neoplasms
1
Hypoxia
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Interventions
Gemcitabine
10
pembrolizumab
7
Cisplatin
7
Oxaliplatin
4
durvalumab
3
Nivolumab
3
130-nm albumin-bound paclitaxel
3
fludarabine
2
Specimen Handling
2
Radiation
2
Ipilimumab
2
Drug Therapy
2
Cyclophosphamide
2
Capecitabine
2
Biopsy
2
tremelimumab
1
trametinib
1
tivozanib
1
tislelizumab
1
silmitasertib
1
pertuzumab
1
peposertib
1
pemigatinib
1
olutasidenib
1
lenvatinib
1
inositol trispyrophosphate
1
futibatinib
1
enasidenib
1
devimistat
1
derazantinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Cholangiocarcinoma
×
inositol trispyrophosphate
×
Clear all
NCT02528526
2015-08-19
OXY1A
University of Zurich
Phase 1/2
Unknown
69 enrolled